Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD07805/47 (brimonidine tartrate) gel 0.5% once daily for moderate to severe facial erythema of rosacea
2012-001044-22Phase 3Completed
- Sponsor
- Galderma
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine in rosacea, sponsored by Galderma. Started Jun 2012; status: completed.
02
Drugs
brimonidine
03
Conditions
rosacea
Beyond the preview
Go deeper on 2012-001044-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001044-22.